ABSTRACT: Pharmacological activation of LRH-1/NR5A2 triggers an anti-inflammatory phenotypic switch in immune cells from individuals with type 1 diabetes and improves human islet engraftment/function
PROVIDER: PRJNA1017470 | ENA |
REPOSITORIES: ENA
ACCESS DATA